Related Experiment Video
Updated: May 11, 2026
14:25
Window on a Microworld: Simple Microfluidic Systems for Studying Microbial Transport in Porous Media
Published on: May 3, 2010
11.3K
A Hydrogel-Based 3D Microfluidic Platform with Optimized Flow and Mass Transfer for Rapid Antimicrobial
Zhihang Yu1,2, Xueshan Xiong1, Jiuxin Qv3
1School of Mechanical Engineering and Automation, Harbin Institute of Technology, Shenzhen, Shenzhen 518055, China.
Analytical Chemistry
|March 8, 2026
Summary
This study presents a novel hydrogel microfluidic platform for rapid antimicrobial susceptibility testing (RAST). The system accurately determines antibiotic effectiveness against bacteria in just 2 hours, significantly speeding up clinical decisions.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Antimicrobial Resistance Research
Background:
- Antibiotic resistance (AMR) poses a critical global health threat, causing millions of deaths annually.
- Timely antimicrobial susceptibility testing (AST) is essential for effective clinical treatment of bacterial infections.
- Current AST methods can be slow, delaying crucial treatment decisions.
Purpose of the Study:
- To develop a safe, rapid, and accurate hydrogel-based 3D microfluidic platform for testing highly pathogenic bacteria.
- To optimize fluid dynamics and mass transfer for enhanced bacterial growth and drug delivery in AST.
- To enable faster determination of minimum inhibitory concentrations (MICs) for clinical applications.
Main Methods:
- Development of a hydrogel-based 3D culture microfluidic chip within a PMMA enclosure.
- Utilized a Christmas tree concentration gradient generator for precise delivery of four drug concentrations.
- Employed theoretical, finite-element method, and experimental analyses to optimize flow and mass transfer.
- Optimized hydrogel porosity (90%) and chamber height (200 μm) for improved performance.
Main Results:
- Demonstrated precise control over drug concentration gradients by adjusting flow-rate and concentration ratios.
- Achieved enhanced mass transfer, bacterial growth, and drug delivery through optimized hydrogel properties.
- Determined the MIC of gentamicin for *Escherichia coli* ATCC 25922 within 2 hours (8-10x faster than standard methods).
- Validated accuracy comparable to conventional AST methods.
Conclusions:
- The developed hydrogel-based 3D microfluidic system offers a safe, efficient, and scalable platform for rapid antimicrobial susceptibility testing (RAST).
- This technology shows significant potential for clinical applications, particularly against highly pathogenic and drug-resistant bacteria.
- Optimized fluid dynamics and mass transfer are key to enhancing the performance of microfluidic AST devices.
